Glycoprotein B of equine herpesvirus type 1 has two recognition sites for subtilisin-like proteases that are cleaved by furin

Journal of General Virology

Volumn 97, Issue 5, 2016, Pages 1218-1228

  Spiesschaert, Bart ^a   Stephanowitz, Heike ^b   Krause, Eberhard ^b   Osterrieder, Nikolaus ^a   Azab, Walid ^a,c  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b LEIBNIZ INSTITUT FÜR MOLEKULARE PHARMAKOLOGIE   (Germany)

^c Zagazig University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

FURIN; GLYCOPROTEIN B; PROTEINASE; SIGNAL PEPTIDE; SUBTILISIN; GLYCOPROTEIN B, SIMPLEXVIRUS; PROTEIN BINDING; VIRUS ENVELOPE PROTEIN;

ARTICLE; EQUID HERPESVIRUS 1; GENE MUTATION; HERPESVIRIDAE; IN VITRO STUDY; INFECTION RATE; MUTATION; NONHUMAN; PRIORITY JOURNAL; VIROGENESIS; AMINO ACID SEQUENCE; BINDING SITE; CHEMISTRY; METABOLISM; MONONUCLEAR CELL; VIROLOGY;

AMINO ACID SEQUENCE; BINDING SITES; FURIN; HERPESVIRUS 1, EQUID; LEUKOCYTES, MONONUCLEAR; MUTATION; PROTEIN BINDING; SUBTILISINS; VIRAL ENVELOPE PROTEINS;

EID: 84964978097     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/jgv.0.000418     Document Type: Article

References (52)

1. Allen, G. P. & Yeargan, M. R. (1987). Use of lambda gt11 and monoclonal antibodies to map the genes for the six major glycoproteins of equine herpesvirus 1. J Virol 61, 2454-2461.
2. Azab, W. & Osterrieder, N. (2012). Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins. J Virol 86, 2031-2044.
3. Azab, W., Kato, K., Arii, J., Tsujimura, K., Yamane, D., Tohya, Y., Matsumura, T. & Akashi, H. (2009). Cloning of the genome of equine herpesvirus 4 strain TH20p as an infectious bacterial artificial chromosome. Arch Virol 154, 833-842.
4. Azab, W., Tsujimura, K., Maeda, K., Kobayashi, K., Mohamed, Y. M., Kato, K., Matsumura, T. & Akashi, H. (2010). Glycoprotein C of equine herpesvirus 4 plays a role in viral binding to cell surface heparan sulfate. Virus Res 151, 1-9.
5. Azab, W., Tsujimura, K., Kato, K., Arii, J., Morimoto, T., Kawaguchi, Y., Tohya, Y., Matsumura, T. & Akashi, H. (2010a). Characterization of a thymidine kinase-deficient mutant of equine herpesvirus 4 and in vitro susceptibility of the virus to antiviral agents. Antiviral Res 85, 389-395.
6. Backovic M., Leser, G. P., Lamb, R. A., Longnecker, R. & Jardetzky, T. S. (2007). Characterization of EBV gB indicates properties of both class I and class II viral fusion proteins. Virology 368, 102-113.
7. Belouzard, S., Chu, V. C. & Whittaker, G. R. (2009). Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites. Proc Natl Acad Sci U S A 106, 5871-5876.
8. Belouzard, S., Millet, J. K., Licitra, B. N. & Whittaker, G. R. (2012). Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 4, 1011-1033.
9. Borchers, K., Thein, R. & Sterner-Kock, A. (2006). Pathogenesis of equine herpesvirus-associated neurological disease: a revised explanation. Equine Vet J 38, 283-287.
10. Bosshart, H., Humphrey, J., Deignan, E., Davidson, J., Drazba, J., Yuan, L., Oorschot, V., Peters, P. J. & Bonifacino, J. S. (1994). The cytoplasmic domain mediates localization of furin to the trans- Golgi network en route to the endosomal/lysosomal system. J Cell Biol 126, 1157-1172.
11. Cai, W. H., Gu, B. & Person, S. (1988). Role of glycoprotein B of herpes simplex virus type 1 in viral entry and cell fusion. J Virol 62, 2596-2604.
12. Claesson-Welsh, L. & Spear, P. G. (1986). Oligomerization of herpes simplex virus glycoprotein B. J Virol 60, 803-806.
13. Csellner, H., Walker, C., Wellington, J. E., McLure, L. E., Love, D. N. & Whalley, J. M. (2000). EHV-1 glycoprotein D (EHV-1 gD) is required for virus entry and cell-cell fusion, and an EHV-1 gD deletion mutant induces a protective immune response in mice. Arch Virol 145, 2371-2385.
14. Czupalla, C., Nürnberg, B. & Krause, E. (2003). Analysis of class I phosphoinositide 3-kinase autophosphorylation sites by mass spectrometry. Rapid Commun Mass Spectrom 17, 690-696.
15. Distler, J. H., Jüngel, A., Kurowska-Stolarska, M., Michel, B. A., Gay, R. E., Gay, S. & Distler, O. (2005). Nucleofection: a new, highly efficient transfection method for primary human keratinocytes*. Exp Dermatol 14, 315-320.
16. Gilkerson, J. R., Love, D. N. & Whalley, J. M. (1998). Epidemiology of equine herpesvirus abortion: searching for clues to the future. Aust Vet J 76, 675-676.
17. Glauser, D. L., Milho, R., Frederico, B., May, J. S., Kratz, A. S., Gillet, L. & Stevenson, P. G. (2013). Glycoprotein B cleavage is important for murid herpesvirus 4 to infect myeloid cells. J Virol 87, 10828-10842.
18. González-Reyes, L., Ruiz-Argüello, M. B., García-Barreno, B., Calder, L., López, J. A., Albar, J. P., Skehel, J. J., Wiley, D. C. & Melero, J. A. (2001). Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc Natl Acad Sci U S A 98, 9859-9864.
19. Goodman, L. B., Loregian, A., Perkins, G. A., Nugent, J., Buckles, E. L., Mercorelli, B., Kydd, J. H., Palù G., Smith, K. C. & other authors (2007). A point mutation in a herpesvirus polymerase determines neuropathogenicity. PLoS Pathog 3, e160.
20. Gu, F., Crump, C. M. & Thomas, G. (2001). Trans-Golgi network sorting. Cell Mol Life Sci 58, 1067-1084.
21. Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H. D. & Garten, W. (1992). Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 360, 358-361.
22. Herrold, R. E., Marchini, A., Fruehling, S. & Longnecker, R. (1996). Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo. J Virol 70, 2049-2054.
23. Kopp, A., Blewett, E., Misra, V. & Mettenleiter, T. C. (1994). Proteolytic cleavage of bovine herpesvirus 1 (BHV-1) glycoprotein gB is not necessary for its function in BHV-1 or pseudorabies virus. J Virol 68, 1667-1674.
24. Lee, E. C., Yu, D., Martinez de Velasco, J., Tessarollo, L., Swing, D. A., Court, D. L., Jenkins, N. A. & Copeland, N. G. (2001). A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73, 56-65.
25. Ma, G., Azab, W. & Osterrieder, N. (2013). Equine herpesviruses type 1 (EHV-1) and 4 (EHV-4)-masters of co-evolution and a constant threat to equids and beyond. Vet Microbiol 167, 123-134.
26. Meindl, A. & Osterrieder, N. (1999). The equine herpesvirus 1 Us2 homolog encodes a nonessential membrane-associated virion component. J Virol 73, 3430-3437.
27. Molloy, S. S., Bresnahan, P. A., Leppla, S. H., Klimpel, K. R. & Thomas, G. (1992). Human furin is a calcium-dependent serine endoprotease that recognizes the sequence Arg-X-X-Arg and efficiently cleaves anthrax toxin protective antigen. J Biol Chem 267, 16396-16402.
28. Neubauer, A., Braun, B., Brandmuller, C., Kaaden, O. R. & Osterrieder, N. (1997). Analysis of the contributions of the equine herpesvirus 1 glycoprotein gB homolog to virus entry and direct cell-to-cell spread. Virology 227, 281-294.
29. Okazaki, K. (2007). Proteolytic cleavage of glycoprotein B is dispensable for in vitro replication, but required for syncytium formation of pseudorabies virus. J Gen Virol 88, 1859-1865.
30. Oliver, S. L., Sommer, M., Zerboni, L., Rajamani, J., Grose, C. & Arvin, A. M. (2009). Mutagenesis of varicella-zoster virus glycoprotein B: putative fusion loop residues are essential for viral replication, and the furin cleavage motif contributes to pathogenesis in skin tissue in vivo. J Virol 83, 7495-7506.
31. Peeters, B., de Wind, N., Hooisma, M., Wagenaar, F., Gielkens, A. & Moormann, R. (1992). Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusion. J Virol 66, 894-905.
32. Pusterla, N., David Wilson, W., Madigan, J. E. & Ferraro, G. L. (2009). Equine herpesvirus-1 myeloencephalopathy: a review of recent developments. Vet J 180, 279-289.
33. Rauh, I. & Mettenleiter, T. C. (1991). Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration. J Virol 65, 5348-5356.
34. Rudolph, J., O’Callaghan, D. J. & Osterrieder, N. (2002). Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). J Vet Med B Infect Dis Vet Public Health 49, 31-36.
35. Seidah, N. G., Benjannet, S., Hamelin, J., Mamarbachi, A. M., Basak, A., Marcinkiewicz, J., Mbikay, M., Chrétien, M & Marcinkiewicz, M. (1999). The subtilisin/kexin family of precursor convertases. Emphasis on PC1, PC2/7B2, POMC and the novel enzyme SKI-1. Ann N Y Acad Sci 885, 57-74.
36. Smith, K. C. & Borchers, K. (2001). A study of the pathogenesis of equid herpesvirus-1 (EHV-1) abortion by DNA in-situ hybridization. J Comp Pathol 125, 304-310.
37. Smith, K. C., Whitwell, K. E., Blunden, A. S., Bestbier, M. E., Scase, T. J., Geraghty, R. J., Nugent, J., Davis-Poynter, N. J. & Cardwell, J. M. (2004). Equine herpesvirus-1 abortion: atypical cases with lesions largely or wholly restricted to the placenta. Equine Vet J 36, 79-82.
38. Sorem, J. & Longnecker, R. (2009). Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells. J Gen Virol 90, 591-595.
39. Spiesschaert, B., Osterrieder, N. & Azab, W. (2015). Comparative analysis of glycoprotein B (gB) of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in cellular tropism and cell-to-cell transmission. Viruses 7, 522-542.
40. Stieneke-Gröber A., Vey, M., Angliker, H., Shaw, E., Thomas, G., Roberts, C., Klenk, H. D & Garten, W. (1992). Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J 11, 2407-2414.
41. Stokes, A., Alber, D. G., Greensill, J., Amellal, B., Carvalho, R., Taylor, L. A., Doel, T. R., Killington, R. A., Halliburton, I. W. & Meredith, D. M. (1996). The expression of the proteins of equine herpesvirus 1 which share homology with herpes simplex virus 1 glycoproteins H and L. Virus Res 40, 91-107.
42. Strive, T., Borst, E., Messerle, M. & Radsak, K. (2002). Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture. J Virol 76, 1252-1264.
43. Sullivan, D. C., Allen, G. P. & O’Callaghan, D. J. (1989). Synthesis and processing of equine herpesvirus type 1 glycoprotein 14. Virology 173, 638-646.
44. Thaa, B., Sinhadri, B. C., Tielesch, C., Krause, E. & Veit, M. (2013). Signal peptide cleavage from GP5 of PRRSV: a minor fraction of molecules retains the decoy epitope, a presumed molecular cause for viral persistence. PLoS One 8, e65548.
45. Thomas, G. (2002). Furin at the cutting edge: from protein traffic to embryogenesis and disease. Nat Rev Mol Cell Biol 3, 753-766.
46. Tischer, B. K., von Einem, J., Kaufer, B. & Osterrieder, N. (2006). Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli. Biotechniques 40, 191-197.
47. Volchkov, V. E., Feldmann, H., Volchkova, V. A. & Klenk, H. D. (1998). Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A 95, 5762-5767.
48. von Einem, J., Smith, P. M., Van de Walle, G. R., O’Callaghan, D. J. & Osterrieder, N. (2007). In vitro and in vivo characterization of equine herpesvirus type 1 (EHV-1) mutants devoid of the viral chemokine-binding glycoprotein G (gG). Virology 362, 151-162.
49. Wellington, J. E., Gooley, A. A., Love, D. N. & Whalley, J. M. (1996a). N-terminal sequence analysis of equine herpesvirus 1 glycoproteins D and B and evidence for internal cleavage of the gene 71 product. J Gen Virol 77, 75-82.
50. Wellington, J. E., Love, D. N. & Whalley, J. M. (1996b). Evidence for involvement of equine herpesvirus 1 glycoprotein B in cell-cell fusion. Arch Virol 141, 167-175.
51. Wise, R. J., Barr, P. J., Wong, P. A., Kiefer, M. C., Brake, A. J. & Kaufman, R. J. (1990). Expression of a human proprotein processing enzyme: correct cleavage of the von Willebrand factor precursor at a paired basic amino acid site. Proc Natl Acad Sci U S A 87, 9378-9382.
52. Zimmer, G., Budz, L. & Herrler, G. (2001). Proteolytic activation of respiratory syncytial virus fusion protein. Cleavage at two furin consensus sequences. J Biol Chem 276, 31642-31650.